Understanding Semaglutide Semaglutide, a GLP-1 receptor agonist approved by the FDA, is a potent treatment for adults dealing with obesity and overweight issues paired with weight-related conditions
Shiojima, Y., Takahashi, M., Takahashi, R., Moriyama, H., Bagchi, D., Bagchi, M., & Akanuma, M
However, there can be side effects for some users, such as nausea and vomiting, and research shows that patients often put weight back on after stopping treatment
High doses of semaglutide (7.2 mg) caused the side effect in 22.9% of participants in experimental trials
The drug enhances these receptors, which help the pancreas make more insulin, in turn helping to reduce blood-sugar levels that can become elevated in people with diabetes